← Leaderboards
David A Stoltz
University Of Iowa
$27,502,140
Attributed
$31,711,375
Total exposure
16
Grants
16
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.4M · FY2008–25$10M$7.5M$5M$2.5M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$45,569,727 · 18
By mechanism
P01$32,395,236 · 12
R01$7,786,256 · 2
DP2$2,265,000 · 1
R38$1,291,596 · 1
T32$1,226,571 · 1
K08$605,068 · 1
Top collaborators
- Joseph Zabner5 shared
- Paul B Mccray4 shared
- Peter S Thorne3 shared
- Lynda S Ostedgaard1 shared
Most similar at University Of Iowa
Same institution · by research overlap
- Joseph Zabner$29,014,505
- Mahmoud Abou Alaiwa$4,553,455
- Kevin L Legge$8,443,120
- Michael J. Welsh$31,109,771
- Xiaopeng Li$3,247,277
Others in their field
Top investigators on “Lung”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$372,040,227
- Chanza Baytop · Westat, Inc.$271,217,917
- Richard K. Wilson · Washington University$201,818,043
- Walter John Curran · Thomas Jefferson University$112,093,071
Research focus
LungCystic FibrosisInfectionFamily SuidaePathogenesisProgramsAffectInflammationAnimal ModelGenesCystic Fibrosis Transmembrane Conductance RegulatorPulmonary Cystic FibrosisResearch PersonnelAirway DiseaseSuccessChronicLifeMorbidity - Disease RateEnsureDisease ProgressionMutationAnimalsProductionPrevention
Grant awards (66)
Pathogenesis and Therapeutic Approaches in Primary Ciliary Dyskinesia$2,363,088
P01 · FY2025 · HL · contact PI
Testing the Contributions of Airway Submucosal Glands and Surface Epithelia to Lung Health$628,851
R01 · FY2025 · HL · contact PI
Lung Health and the Environment Training Program$501,397
T32 · FY2025 · HL · contact PI
Core A: Administrative$393,849
P01 · FY2025 · HL · contact PI
Project 2$393,848
P01 · FY2025 · HL · contact PI
Testing the Contributions of Airway Submucosal Glands and Surface Epithelia to Lung Health$627,630
R01 · FY2024 · HL · contact PI
Animal Models Core$593,055
P01 · FY2024 · HL · contact PI
Climate Change and Lung Health Training Program$436,679
T32 · FY2024 · HL · contact PI
Iowa StARR Scholars Program$322,361
R38 · FY2024 · HL · contact PI
Testing the Contributions of Airway Submucosal Glands and Surface Epithelia to Lung Health$629,471
R01 · FY2023 · HL · contact PI
Animal Models Core$599,660
P01 · FY2023 · HL · contact PI
Iowa StARR Scholars Program$322,361
R38 · FY2023 · HL · contact PI
Climate Change and Lung Health Training Program$288,495
T32 · FY2023 · HL · contact PI
Origins of Cystic Fibrosis Airway Disease$2,293,311
P01 · FY2022 · HL · contact PI
Core A: Animals Models-Stoltz$712,238
P01 · FY2022 · HL · contact PI
Testing the Contributions of Airway Submucosal Glands and Surface Epithelia to Lung Health$609,707
R01 · FY2022 · HL
Animal Models Core$599,660
P01 · FY2022 · HL · contact PI
Project 1: Mucociliary Transport in Cystic Fibrosis Lung Disease$371,812
P01 · FY2022 · HL · contact PI
Iowa StARR Scholars Program$322,426
R38 · FY2022 · HL · contact PI
Porcine PPG Administration Core$62,341
P01 · FY2022 · HL · contact PI
Origins of Cystic Fibrosis Airway Disease$2,293,803
P01 · FY2021 · HL · contact PI
Airway Alkalinization and Repurposing Tromethamine as a Therapeutic Approach in Cystic Fibrosis$1,053,550
R01 · FY2021 · HL · contact PI
Core A: Animals Models-Stoltz$712,730
P01 · FY2021 · HL · contact PI
Animal Models Core$608,272
P01 · FY2021 · HL · contact PI
Project 1: Mucociliary Transport in Cystic Fibrosis Lung Disease$371,812
P01 · FY2021 · HL · contact PI
Iowa StARR Scholars Program$324,448
R38 · FY2021 · HL · contact PI
Porcine PPG Administration Core$62,341
P01 · FY2021 · HL · contact PI
Origins of Cystic Fibrosis Airway Disease$2,294,370
P01 · FY2020 · HL · contact PI
Airway Alkalinization and Repurposing Tromethamine as a Therapeutic Approach in Cystic Fibrosis$1,054,599
R01 · FY2020 · HL · contact PI
Core A: Animals Models-Stoltz$713,297
P01 · FY2020 · HL · contact PI
Animal Models Core$610,550
P01 · FY2020 · HL · contact PI
Project 1: Mucociliary Transport in Cystic Fibrosis Lung Disease$371,812
P01 · FY2020 · HL · contact PI
Porcine PPG Administration Core$62,341
P01 · FY2020 · HL · contact PI
Origins of Cystic Fibrosis Airway Disease$2,295,540
P01 · FY2019 · HL · contact PI
Airway Alkalinization and Repurposing Tromethamine as a Therapeutic Approach in Cystic Fibrosis$1,055,623
R01 · FY2019 · HL · contact PI
Core A: Animal Models$796,251
P01 · FY2019 · HL · contact PI
Core A: Animals Models-Stoltz$714,467
P01 · FY2019 · HL · contact PI
Project 1: Mucociliary Transport in Cystic Fibrosis Lung Disease$371,812
P01 · FY2019 · HL · contact PI
Porcine PPG Administration Core$62,341
P01 · FY2019 · HL · contact PI
Origins of Cystic Fibrosis Airway Disease$2,318,240
P01 · FY2018 · HL · contact PI
Airway Alkalinization and Repurposing Tromethamine as a Therapeutic Approach in Cystic Fibrosis$1,056,522
R01 · FY2018 · HL · contact PI
Core A: Animal Models$798,107
P01 · FY2018 · HL · contact PI
Core A: Animals Models-Stoltz$736,685
P01 · FY2018 · HL · contact PI
Project 1: Mucociliary Transport in Cystic Fibrosis Lung Disease$371,812
P01 · FY2018 · HL · contact PI
Porcine PPG Administration Core$62,341
P01 · FY2018 · HL · contact PI
Airway Alkalinization and Repurposing Tromethamine as a Therapeutic Approach in Cystic Fibrosis$1,070,303
R01 · FY2017 · HL · contact PI
Animal Core$800,140
P01 · FY2017 · HL · contact PI
Core A: Animal Models$799,909
P01 · FY2017 · HL · contact PI
Imaging Core$203,850
P01 · FY2017 · HL · contact PI
Core A: Animal Models$805,502
P01 · FY2016 · HL · contact PI
Animal Core$800,140
P01 · FY2016 · HL · contact PI
Imaging Core$203,850
P01 · FY2016 · HL · contact PI
Core A: Animal Models$813,635
P01 · FY2015 · HL · contact PI
Animal Core$795,837
P01 · FY2015 · HL · contact PI
Imaging Core$199,547
P01 · FY2015 · HL · contact PI
Animal Core$799,299
P01 · FY2014 · HL · contact PI
Imaging Core$198,101
P01 · FY2014 · HL · contact PI
Animal Core$769,575
P01 · FY2013 · HL · contact PI
Imaging Core$194,065
P01 · FY2013 · HL · contact PI
Airway Goblet Cells: Friend or Foe?$2,265,000
DP2 · FY2012 · HL · contact PI
Paraoxonase-2 S311C Polymorphism Alters Glycosylation and Lactonase Activity$126,267
K08 · FY2011 · AI · contact PI
Paraoxonase-2 S311C Polymorphism Alters Glycosylation and Lactonase Activity$126,267
K08 · FY2010 · AI · contact PI
Paraoxonase-2 S311C Polymorphism Alters Glycosylation and Lactonase Activity$50,000
K08 · FY2010 · AI · contact PI
Paraoxonase-2 S311C Polymorphism Alters Glycosylation and Lactonase Activity$126,267
K08 · FY2009 · AI · contact PI
Paraoxonase-2 S311C Polymorphism Alters Glycosylation and Lactonase Activity$50,000
K08 · FY2009 · AI · contact PI
Paraoxonase-2 S311C Polymorphism Alters Glycosylation and Lactonase Activity$126,267
K08 · FY2008 · AI · contact PI